News Release
You can select the year, month, and category you wish to view.
- All
- Business Development
- Drug Discovery
- General Meeting of Shareholders
- Financial Information
- Other
-
2025.03.18
Announcement of a presentation at the 22nd Annual Meeting of the Japanese Society of Medical Oncology (JSMO2025)
(381KB)
-
2025.03.18
Report on the American Society of Peripheral Nerve (ASPN) 2025 Annual Meeting Presentation and Participation
(439KB)
-
2025.03.18
Announcement of the results of the third-phase clinical trial (physician-led clinical trial) for LT-5001
(237KB)
-
2025.03.18
Report on participation in BioEurope 2024
(305KB)
-
2025.03.18
Announcement of the Conclusion of a Joint Research Agreement with the National Cancer Center
(259KB)
-
2025.03.18
Report on the Investigator Meeting for the PC-SOD Phase II Clinical Trial
(931KB)
-
2025.03.18
Announcement of PMDA face-to-face advice (consultation after completion of Phase II trials) for PC-SOD.
(179KB)
-
2025.03.18
Invited Lecture by our CEO, Tohru Mizushima, at APOPC2024
(884KB)
-
2025.03.18
Report on the JHVS (co-hosted with BioJapan 2024) exhibition
(685KB)
-
2025.03.18
Announcement of the start of the second phase of the first clinical trial of PC-SOD
(176KB)
